We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+19.82%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.84B
AUM Growth
+$680M
Cap. Flow
+$205M
Cap. Flow %
7.2%
Top 10 Hldgs %
32.58%
Holding
110
New
34
Increased
20
Reduced
17
Closed
25

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$55M
2
LLY icon
Eli Lilly
LLY
+$52.4M
3
MCK icon
McKesson
MCK
+$51.5M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$41.6M
5
ABBV icon
AbbVie
ABBV
+$40.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$114M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$30.6M
3
XYZ
Block Inc
XYZ
+$29.5M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$20.8M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Healthcare 79.08%
2 Financials 0.38%
3 Consumer Discretionary 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
101
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
– –
-200,000
Closed -$22.3M
XYZ
102
Block Inc
XYZ
$47.4B
– –
-181,509
Closed -$29.5M
KRTX
103
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-137,960
Closed -$10.7M
ZEN
104
DELISTED
ZENDESK INC
ZEN
– –
-67,034
Closed -$6.9M
IMMU
105
DELISTED
Immunomedics Inc
IMMU
– –
-1,343,570
Closed -$114M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q4 2020 Portfolio in Review

As of Q4 2020, PFM Health Sciences held 110 positions worth $2.84B, up 31% from $2.16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences deployed $205M of net new capital in Q4 2020, opening 34 new positions and adding to 20 existing holdings. Its largest new stake was Universal Health Services: 442,044 shares worth $60.8M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $30.6M trimmed.

  • PFM Health Sciences's largest Q4 2020 buy was Universal Health Services: 442,044 shares worth $60.8M.
  • PFM Health Sciences added most to Acadia Pharmaceuticals in Q4 2020, an estimated $41.6M increase.
  • PFM Health Sciences's biggest Q4 2020 reduction was BioMarin Pharmaceuticals, cutting an estimated $30.6M.
  • PFM Health Sciences fully exited Immunomedics Inc in Q4 2020, selling an estimated $114M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $2.84B portfolio in Q4 2020.
  • PFM Health Sciences opened 34 new positions and closed 25 in Q4 2020.
  • PFM Health Sciences's portfolio value rose 31% quarter-over-quarter to $2.84B.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.